Tuberculosis due to Mycobacterium bovis after alemtuzumab administration

被引:20
作者
Abad, S
Gyan, E
Moachon, L
Bouscary, D
Sicard, D
Dreyfus, F
Blanche, P
机构
[1] Univ Paris 05, Hop Cochin St Vincent de Paul, Serv Med Interne 2, F-75679 Paris 14, France
[2] Univ Paris 05, Hop Cochin St Vincent de Paul, Hematol Serv, F-75679 Paris, France
[3] Univ Paris 05, Hop Cochin St Vincent de Paul, Serv Pharmacovigilance, F-75679 Paris 14, France
关键词
D O I
10.1086/375690
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We describe a patient with relapsing B chronic lymphocytic leukemia who developed systemic bacille Calmette-Guerin infection (BCGitis) after administration of alemtuzumab (Campath-1H).
引用
收藏
页码:E27 / E28
页数:2
相关论文
共 4 条
[1]   Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study [J].
Keating, MJ ;
Flinn, I ;
Jain, V ;
Binet, JL ;
Hillmen, P ;
Byrd, J ;
Albitar, M ;
Brettman, L ;
Santabarbara, P ;
Wacker, B ;
Rai, KR .
BLOOD, 2002, 99 (10) :3554-3561
[2]  
MICHAEL E, 1995, ARTHRITIS RHEUM, V38, P1589
[3]   Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia [J].
Osterborg, A ;
Dyer, MJS ;
Bunjes, D ;
Pangalis, GA ;
Bastion, Y ;
Catovsky, D ;
Mellstedt, H ;
Rankin, E ;
Tsekouras, C ;
Pangalis, GA ;
Cavalli, F ;
Sessa, C ;
Huhn, D ;
Marcus, R ;
Maughan, T ;
Poynton, C ;
Nissen, N ;
Carney, D ;
Brittinger, G ;
Uppenkamp, M ;
Elonen, E ;
Teerenhovi, L ;
Engert ;
Willemze, R ;
KluinNelemans, J ;
Thomas, J ;
Epenetos, AA ;
Nethersell, A ;
Dyer, M ;
Catovsky, D ;
Dicato, M ;
Bastion, Y ;
Coiffier, B ;
Ranada, JMF ;
Crowther, D ;
Woll, P ;
Raemakaers, J ;
dePauw, B ;
Degos, L ;
Gissellbrecht ;
Reiffers, J ;
Mellstedt, H ;
Fassas, A ;
Anagnostopoulos, A ;
Bunjes, D ;
Jaeger, U ;
Stahel, RA .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (04) :1567-1574
[4]  
WILLEMZE R, 1992, BONE MARROW TRANSPL, V9, P255